Navigation Links
PRISYM ID's Medica Greatly Simplifies FDA and MHRA Compliance
Date:3/22/2010

elling requirements. PRISYM Medica has been designed to increase collaboration and lessen the expense and inefficiency of validation, by allowing all relevant parties access to the design, review and validation process online. There is no need to install the relevant software at each location and the web-based nature of the solution also means that it is simpler to involve people simultaneously at each step of the label production process, making collaboration much easier.

PRISYM Medica is a simple to use label design and management application which allows you to develop, review, validate and distribute labels aiding with compliance for the Food and Drug Administration (FDA) and the Medicines and Healthcare products Regulatory Agency (MHRA) regulations, among others. It enables unique serialised codes to be automatically applied in the format necessary to meet local legislative requirements. Where appropriate, live batch information, destination information and intelligent serial numbers needed for compliance with international regulations can be passed for printing automatically.

    PRISYM Medica benefits include:

    - Secure, automated and accurate labelling for globally
      distributed life science products
    - Web-based using Microsoft Internet Explorer, allowing quick
      deployment and easy use
    - Automated printing and reporting of identity codes to comply with
      national and international standards
    - A proactive review and approval work engine, increasing the
      accuracy of layout and data used on labels and reducing the likelihood
      of product recalls
    - Support in meeting with FDA, MHRA and other compliance
      regulations
    - Template-based label development, minimising the changes needed
      for
'/>"/>
SOURCE PRISYM ID
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Markets to 2020 - Novel Therapeutic ... Newly Diagnosed and Recurrent GBM ... Glioblastoma Multiforme Therapeutics in ...
(Date:8/28/2014)... 2014  Robotic surgery is creating buzz among ... the promise of improved outcomes and the potential ... surgical robots and market pressures to use this ... their robotic surgery training programs and ensure proper ... ECRI Institute ( www.ecri.org ), a nonprofit ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... new market research report is available ... Therapeutics to 2020 - Broadened Diagnostic ... Drive Market Growth despite Patent Expirations ... ADHD Therapeutics to 2020 ...
Breaking Medicine Technology:Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 "I have ... neck surgeries, as well as many other surgeries in my ... from Richmond, Texas. "During my stays, I was unable to ... many other ailments. Two nurses freely had to physically rotate ... on either side of me and pulled the sheets. This ...
(Date:8/29/2014)... Gwyneth Paltrow, Beyonce and Angelina Jolie are only among ... all over the United States, to find the best fat ... quickly shed excess fat. And, recent inspiration has come from ... gluten products, eggs and meats for ingredients like goji berries ... this type of diet, one must be a celebrity to ...
(Date:8/29/2014)... August 29, 2014 Hep-Lock IV lines ... can be difficult to keep in place comfortably. "I ... infiltration and discomfort caused by medical tape," said an ... way to secure hep-lock IV lines." , The patent-pending ... medical tape, which avoids irritated skin and allergic reactions. ...
(Date:8/29/2014)... Spain Saturday 30 August 2014: The ACCA Clinical ... the App Store and Google Play. , When ... can make the difference and instant access to ... the Acute Cardiovascular Care Association (ACCA) of the ... allowing professionals to have immediate access to diagnostics ...
(Date:8/29/2014)... 2014 When subjected to validation using ... to be one of the most consistent instruments for ... the Hartman Personality Profile, and the “Big 5” are ... Each of these testing tools uses a short questionnaire ... personality type has been identified, the test results can ...
Breaking Medicine News(10 mins):Health News:InventHelp® Client Develops Equipment for Surgical and Bedridden Patients (HCD-279) 2Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 2Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 3Health News:Mobile app on emergency cardiac care aids best decisions in seconds 2Health News:Mobile app on emergency cardiac care aids best decisions in seconds 3Health News:DISC Personality Tests Demonstrate High Rates of “Test-Retest Reliability” 2Health News:DISC Personality Tests Demonstrate High Rates of “Test-Retest Reliability” 3
... , BOTHELL, Wash., Aug. 31 SCOLR ... Stephen J. Turner as Chief Executive Officer and President as of August ... positions terminated on August 28 by mutual agreement. Dr. Morra will ... , Mr. Turner has been Vice President and Chief ...
... , , Briefing ... , MINNEAPOLIS, Aug. 31 The Health Care Compliance ... the new federal health information data breach notification rule during Health Information ... be held on Thursday, September 17, 2009, 12 Noon Central Time. , ...
... , , GRAND RAPIDS, Mich., ... notebooks and pencils, Produce for Kids, a program that teaches families about ... to add fruits and vegetables to their back to school shopping lists ... From September 6 to October 3, a portion of sales of sponsored ...
... of complications , MONDAY, Aug. 31 (HealthDay News) -- Having ... as safe as a conventional hospital birth, a new study ... may have a lower rate of complications, according to the ... . , Even though the study was conducted in ...
... metastatic ovarian cancer could be treated with a ... An initial study in patients conducted jointly by the ... University Hospital has found that the treatment has no ... to be able to target radiotherapy in this way," ...
... PROVIDENCE, RI Rhode Island Hospital has received an ... (NIH) grant to fund its Center of Biomedical Research ... Rhode Island Hospital,s COBRE CCRD offers cancer researchers access ... emerging field of proteomics. The 5-year grant from ...
Cached Medicine News:Health News:SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO 2Health News:SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO 3Health News:HCCA Web Conference Addresses Health Information Security & Data Breach Under HITECH Act, September 17, 2009, 12 Noon Central 2Health News:HCCA Web Conference Addresses Health Information Security & Data Breach Under HITECH Act, September 17, 2009, 12 Noon Central 3Health News:Do Good When You Shop and Help Educate a Generation of Healthy Kids 2Health News:Home Birth With Midwife As Safe As Hospital Birth: Study 2Health News:Home Birth With Midwife As Safe As Hospital Birth: Study 3Health News:New treatment in sight for ovarian cancer 2Health News:Rhode Island Hospital awarded $11 million, 5-year renewal 2Health News:Rhode Island Hospital awarded $11 million, 5-year renewal 3
Lambotte periosteal elevators....
OHL periosteal elevator, 19 cm, 7-1/2"....
Sedillot periosteal elevator, 16 mm, sharp, 7"....
Periosteal elevator #9H, 17.5 cm, 7"....
Medicine Products: